Gene · 8784
Papers4,557
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
721 to 740 of 4,557
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Phenotypic signatures of immune selection in HIV-1 reservoir cells. | Nature | 2023 | 36599977 | PubTator, text mining | PubMed |
| IL-10-producing Th1 cells possess a distinct molecular signature in malaria | J Clin Invest | 2023 | 36594463 | PubTator, text mining | PubMed |
| Spontaneous, naturally occurring cancers in non-human primates as a translational model for cancer immunotherapy. | J Immunother Cancer | 2023 | 36593067 | PubTator, text mining | PubMed |
| The ectonucleotidase CD39 identifies tumor-reactive CD8+ T cells predictive of immune checkpoint blockade efficacy in human lung cancer. | Immunity | 2023 | 36574773 | PubTator, text mining | PubMed |
| Impact of BSG/CD147 gene expression on diagnostic, prognostic and therapeutic strategies towards malignant cancers and possible susceptibility to SARS-CoV-2. | Mol Biol Rep | 2023 | 36574092 | PubTator, text mining | PubMed |
| Targeting Co-Stimulatory Receptors of the TNF Superfamily for Cancer Immunotherapy. | BioDrugs | 2023 | 36571696 | PubTator, text mining | PubMed |
| Altered phenotypic and metabolic characteristics of FOXP3+CD3+CD56+ natural killer T (NKT)-like cells in human malignant pleural effusion. | Oncoimmunology | 2023 | 36567801 | PubTator, text mining | PubMed |
| Staphylococcal phosphatidylglycerol antigens activate human T cells via CD1a. | Nat Immunol | 2023 | 36550321 | PubTator, text mining | PubMed |
| Increased Percentage of CD8+CD28- Regulatory T Cells With Fingolimod Therapy in Multiple Sclerosis. | Neurol Neuroimmunol Neuroinflamm | 2023 | 36535763 | PubTator, text mining | PubMed |
| Mature dendritic cells enriched in regulatory molecules may control regulatory T cells and the prognosis of head and neck cancer. | Cancer Sci | 2023 | 36529525 | PubTator, text mining | PubMed |
| Engineering amino acid uptake or catabolism promotes CAR T-cell adaption to the tumor environment. | Blood Adv | 2023 | 36521029 | PubTator, text mining | PubMed |
| TCRconv: predicting recognition between T cell receptors and epitopes using contextualized motifs. | Bioinformatics | 2023 | 36477794 | PubTator, text mining | PubMed |
| Meta-Analysis of Human Cancer Single-Cell RNA-Seq Datasets Using the IMMUcan Database. | Cancer Res | 2023 | 36459564 | PubTator, text mining | PubMed |
| Improving head and neck cancer therapies by immunomodulation of the tumour microenvironment. | Nat Rev Cancer | 2023 | 36456755 | PubTator, text mining | PubMed |
| IL-2-based approaches to Treg enhancement. | Clin Exp Immunol | 2023 | 36399073 | PubTator, text mining | PubMed |
| scHumanNet: a single-cell network analysis platform for the study of cell-type specificity of disease genes. | Nucleic Acids Res | 2023 | 36350625 | PubTator, text mining | PubMed |
| Unlocking the potential of agonist antibodies for treating cancer using antibody engineering. | Trends Mol Med | 2023 | 36344331 | PubTator, text mining | PubMed |
| Comprehensive analysis of the immunological implication and prognostic value of CXCR4 in non-small cell lung cancer. | Cancer Immunol Immunother | 2023 | 36308553 | PubTator, text mining | PubMed |
| Prognostic biomarkers correlated with immune infiltration in non-small cell lung cancer. | FEBS Open Bio | 2023 | 36282125 | PubTator, text mining | PubMed |
| Identification of tumor-specific neoantigens and immune clusters of hepatocellular carcinoma for mRNA vaccine development. | J Cancer Res Clin Oncol | 2023 | 36239794 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8784/papers?page=37